Nectar Lifesciences Limited

NSEI:NECLIFE Stock Report

Market Cap: ₹7.7b

Nectar Lifesciences Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Amit Chadah

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.6yrs
CEO ownershipn/a
Management average tenure1.7yrs
Board average tenure4yrs

Recent management updates

Recent updates

Nectar Lifesciences Limited (NSE:NECLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Feb 19
Nectar Lifesciences Limited (NSE:NECLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Dec 22
Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?

Jun 16
Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?

Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Jun 21
Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Jul 29
Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Is Nectar Lifesciences Limited (NSE:NECLIFE) A Risky Dividend Stock?

Feb 25
Is Nectar Lifesciences Limited (NSE:NECLIFE) A Risky Dividend Stock?

Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet

Jan 21
Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet

Zooming in on NSE:NECLIFE's 0.3% Dividend Yield

Nov 02
Zooming in on NSE:NECLIFE's 0.3% Dividend Yield

Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Sep 07
Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

If You Had Bought Nectar Lifesciences (NSE:NECLIFE) Stock A Year Ago, You Could Pocket A 47% Gain Today

Aug 09
If You Had Bought Nectar Lifesciences (NSE:NECLIFE) Stock A Year Ago, You Could Pocket A 47% Gain Today

The Nectar Lifesciences (NSE:NECLIFE) Share Price Has Gained 47% And Shareholders Are Hoping For More

Aug 09
The Nectar Lifesciences (NSE:NECLIFE) Share Price Has Gained 47% And Shareholders Are Hoping For More

What You Can Learn From Nectar Lifesciences Limited's (NSE:NECLIFE) P/E

Jul 13
What You Can Learn From Nectar Lifesciences Limited's (NSE:NECLIFE) P/E

CEO

Amit Chadah (53 yo)

3.6yrs

Tenure

Mr. Amit Chadah serves as the Chief Executive Officer of Nectar Lifesciences Limited since October 30, 2020. He was President of Business Development until October 30, 2020. He has joined the Nectar Lifesc...


Leadership Team

NamePositionTenureCompensationOwnership
Sanjiv Goyal
Chairman & MDno data₹20.49m44.35%
₹ 3.4b
Puneet Sud
Director of Operations & Wholetime Director1.7yrs₹3.52mno data
Amit Chadah
Chief Executive Officer3.6yrsno datano data
Sushil Kapoor
Chief Financial Officer1.5yrsno datano data
Neha Vaishnav
Company Secretary & Compliance Officer1.4yrsno datano data

1.7yrs

Average Tenure

59.5yo

Average Age

Experienced Management: NECLIFE's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Sanjiv Goyal
Chairman & MDno data₹20.49m44.35%
₹ 3.4b
Puneet Sud
Director of Operations & Wholetime Director1.7yrs₹3.52mno data
Ajay Swaroop
Independent Non-Executive Director13.8yrs₹125.00kno data
Meena Verma
Nominee Director5.3yrs₹80.00kno data
Rupinder Tewari
Independent & Non-Executive Director5.3yrs₹155.00kno data
Kuldip Bhasin
Independent & Non-Executive Director2.7yrs₹155.00kno data
Indu Kaur
Independent & Non-Executive Director1.8yrs₹95.00kno data

4.0yrs

Average Tenure

63yo

Average Age

Experienced Board: NECLIFE's board of directors are considered experienced (4 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.